We are live on
!
Find out more
LSC
Lesa Sroufe & Co Portfolio holdings
AUM
$140M
1-Year Est. Return
53.13%
This Fund
S&P 500
This Quarter
Est. Return
-8.16%
1 Year Est. Return
+53.13%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$172M
AUM Growth
-$25.3M
(-13%)
Cap. Flow
-$8.65M
Cap. Flow
% of AUM
-5.03%
Top 10 Holdings %
Top 10 Hldgs %
44.42%
Holding
47
New
4
Increased
5
Reduced
20
Closed
6
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cameco
CCJ
|
+$7.49M |
| 2 |
MDC
M.D.C. Holdings, Inc.
MDC
|
+$7.13M |
| 3 |
Deutsche Bank
DB
|
+$511K |
| 4 |
Meta Platforms (Facebook)
META
|
+$208K |
| 5 |
TransAlta
TAC
|
+$121K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teva Pharmaceuticals
TEVA
|
+$8.56M |
| 2 |
MDR
McDermott International
MDR
|
+$7.71M |
| 3 |
ATI
ATI
|
+$6.06M |
| 4 |
CHL
China Mobile Limited
CHL
|
+$370K |
| 5 |
Pfizer
PFE
|
+$246K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 20.23% |
| 2 | Financials | 14.83% |
| 3 | Utilities | 12.46% |
| 4 | Materials | 8.73% |
| 5 | Consumer Discretionary | 8.43% |
Similar funds
CPC
JD6
MWM
VEM
SM
WCM
SCM
CFG
Lesa Sroufe & Co's Q3 2014 Portfolio in Review
As of Q3 2014, Lesa Sroufe & Co held 47 positions worth $172M, down 13% from $197M the previous quarter. Its ten largest holdings account for 44% of the portfolio.
Lesa Sroufe & Co withdrew a net $8.65M in Q3 2014, closing 6 positions and reducing 20 holdings. Its most notable exit was Teva Pharmaceuticals, an estimated $8.56M position sold in full.
By sector, the portfolio is most concentrated in Energy at 20% of assets, up from 16% a quarter earlier, followed by Financials and Utilities.
Against the trend, Lesa Sroufe & Co opened a new position in Cameco worth $6.75M.
- Lesa Sroufe & Co's largest Q3 2014 buy was Cameco: 382,020 shares worth $6.75M.
- Lesa Sroufe & Co added most to Deutsche Bank in Q3 2014, an estimated $511K increase.
- Lesa Sroufe & Co's biggest Q3 2014 reduction was China Mobile Limited, cutting an estimated $370K.
- Lesa Sroufe & Co fully exited Teva Pharmaceuticals in Q3 2014, selling an estimated $8.56M.
- Lesa Sroufe & Co's ten largest holdings make up 44% of its $172M portfolio in Q3 2014.
- Lesa Sroufe & Co opened 4 new positions and closed 6 in Q3 2014.
- Lesa Sroufe & Co's portfolio value fell 13% quarter-over-quarter to $172M.
Based on Lesa Sroufe & Co's 13F filing for Q3 2014, filed 5 Nov 2014.